Opinion | Newsom vs Trump: The Mockery War and the Theatre of American Politics

Politics as Mockery, Mockery as Politics

Every democracy invents its own theatre. In ancient Athens, politics and performance were inseparable. In Rome, gladiatorial contests doubled as political propaganda. In modern America, the stage has shifted to television studios, social media feeds, and, increasingly, to the satirical battlefield where politics and mockery are indistinguishable.

Enter Gavin Newsom and Donald Trump. Two men, both masters of image, both fluent in the language of spectacle, now caught in a duel that is as much about ridicule as it is about policy. This is not merely a clash of ideologies. It is a mockery war. And in a nation where entertainment and governance are so entwined, mockery is not incidental. It is strategy.

Trump has long wielded insult as a weapon. “Crooked Hillary.” “Sleepy Joe.” “Little Marco.” His nicknames are not just jokes; they are linguistic branding. They reduce opponents to caricatures that stick in the public consciousness. Newsom, by contrast, has refined a more elegant form of mockery—polished, sardonic, laced with Californian confidence. Where Trump shouts, Newsom smirks. Where Trump bludgeons, Newsom parries.

The duel between them tells us more about the state of American democracy than any policy paper. It shows that power in 2025 is won not merely in debates or legislatures, but in the arena of derision.

Trump’s Politics of Humiliation

Donald Trump’s political rise was inseparable from mockery. His 2016 rallies were carnivals of insult, where complex issues were boiled down to jeers. His presidency thrived on the spectacle of denigration—of enemies, of allies, even of his own appointees.

Mockery was not a by-product. It was a deliberate tactic. In psychological terms, humiliation destabilises. It strips opponents of gravitas. In media terms, it generates clips, memes, and endless amplification. Trump instinctively understood that in an age of fragmented attention, the sharpest insult outperforms the most reasoned argument.

But mockery has a price. It corrodes civic trust, normalises cruelty, and reduces politics to theatre without substance. What began as branding evolved into a governing style, leaving institutions weakened and citizens jaded.

Newsom’s Politics of Poise

Gavin Newsom represents a different model. Groomed in the image-conscious politics of California, he deploys mockery with finesse. His jabs are subtler, often cloaked in policy rebuttals or moral appeals. He presents himself as the adult in the room, yet relishes the opportunity to land a well-timed quip.

In debates, Newsom’s mockery is performative but controlled. His strategy is to project competence while puncturing Trump’s bluster. Where Trump relies on raw derision, Newsom weaponises irony. His smirk is as calculated as Trump’s sneer.

Newsom’s strength is that he appeals to audiences weary of chaos yet unwilling to forgo spectacle. He does not reject the theatre of politics—he refashions it. In the mockery war, he is not the comedian but the satirist.

The Media as Battlefield

Neither Trump nor Newsom fights this war alone. The media amplifies every jab, every insult, every viral moment. Cable networks dissect quips as though they were policy announcements. Social media algorithms reward derision with virality.

Mockery thrives in this environment because it is shareable. A joke fits in a tweet; a policy brief does not. A meme travels faster than a manifesto. Trump and Newsom understand this instinctively. Both play not only to voters but to the echo chambers where mockery becomes identity.

Yet the media is not merely a mirror. It is a participant. By amplifying mockery, it reinforces the very dynamics it critiques. The mockery war is therefore not only between Trump and Newsom, but between spectacle and substance in the American psyche.

Mockery in politics is not new. Winston Churchill wielded it with devastating wit. Margaret Thatcher disarmed opponents with biting sarcasm. Ronald Reagan turned criticism into humour with genial ease.

But the difference in 2025 is the scale. Social media ensures that every insult, every smirk, every mocking video is instantaneously global. The speed of circulation means that mockery can shape narratives before facts are even verified.

This accelerates polarisation. Supporters see mockery as strength; opponents see it as cruelty. In the process, politics itself becomes parody.

Mockery as Strategy, Not Distraction

**Gov. Gavin Newsom greets President Trump at LAX in January 2025. (LA Times)**

It is tempting to dismiss mockery as mere entertainment. But that would be a mistake. Mockery is strategic. It frames opponents, defines debates, and determines who controls the narrative.

For Trump, mockery creates loyalty. His supporters see his insults as authenticity, a willingness to “say what others won’t.” For Newsom, mockery creates contrast. His jabs reassure his base that competence can coexist with confidence.

In a fractured media ecosystem, both strategies work. Mockery is not a distraction from politics. It is politics.

Yet there are dangers. The first is the erosion of seriousness. When politics becomes theatre, citizens may stop believing that governance matters. Cynicism thrives where mockery dominates.

The second is escalation. Mockery breeds counter-mockery, pushing discourse ever further into cruelty. What begins as parody risks becoming poison.

The third is vulnerability. Authoritarian regimes abroad exploit America’s mockery war as evidence of dysfunction. To Beijing or Moscow, the sight of leaders trading insults is propaganda gold, proof that democracy is unserious.

Ultimately, the mockery war only works if voters reward it. The question is whether citizens will continue to prioritise spectacle over substance. Will they share the meme or read the policy? Will they laugh at the insult or interrogate the plan?

Democracy survives not by the quality of mockery but by the quality of judgement. If voters treat politics as comedy, governance becomes tragedy.

Why This Still Matters

The duel between Newsom and Trump is not simply a rivalry between two men. It is a reflection of what American politics has become: a theatre of mockery where image often overwhelms substance.

This matters because mockery, once peripheral, is now central to power. It defines campaigns, erodes trust, and shapes the global perception of democracy. The question is not whether mockery will persist—it will. The question is whether America can balance spectacle with seriousness, satire with strategy, humour with humanity.

The mockery war is not entertainment. It is the battleground on which the future of American democracy is being fought.

‍About the Author‍

Anonymous is a private guest contributor of WTM MEDIA. Through Why These Matter, they examines the intersections of ethics, geo-politics, and government leadership—bringing clarity to issues that shape people, influence culture, and determine the future of global society.

‍

The City Must Learn to Live With Water

The modern city has spent more than a century attempting to make water disappear. Rain falls onto roofs, roads and pavements. Gutters collect it. Drains capture it. Pipes bury it. Pumps move it. Rivers are channelled. Wetlands are filled. Coastlines are defended. The engineering objective has largely been straightforward: separate water from urban life as efficiently as possible. That model is reaching its limits. Around 600 million urban residents already live with significant annual flood hazard, according to the World Bank. Globally, 1.81 billion people live in flood-prone areas, while annual urban flood losses could approach $50 billion by 2050. Rapid urbanisation, ageing drainage infrastructure, land subsidence and changing rainfall patterns are interacting with the basic physical reality that cities have covered enormous portions of naturally absorbent ground with concrete and asphalt. Yet the consequential story is not simply that cities need bigger drains. A different philosophy of urban resilience is emerging: parks designed to flood temporarily; streets shaped to carry cloudbursts; wetlands restored as infrastructure; plazas capable of storing stormwater; permeable landscapes that absorb rainfall; buildings elevated or adapted to tolerate inundation; sensors that reveal water movement in real time; and neighbourhoods organised around the understanding that some water cannot — and perhaps should not — be engineered away. The World Bank increasingly describes effective urban flood management as an integration of grey infrastructure, green infrastructure, nature-based systems, planning, warning systems and institutional reform, rather than reliance on any single engineering intervention. The conceptual reversal is enormous. For generations, successful urbanisation meant controlling nature sufficiently to construct the city. The next generation of urbanism may require something more intelligent: designing the city so nature can still function inside it.

The Price of Money Is Becoming Political Again

For much of the post-financial-crisis era, wealthy economies became accustomed to an extraordinary condition: money was cheap. Governments could borrow heavily, companies could finance expansion at modest rates, asset prices could rise on abundant liquidity, and households learned to treat low-cost mortgages as something approaching economic normality. That world is disappearing fast. Across major economies, long-term government borrowing costs have climbed towards levels not seen for years or decades. On 17 August, the US 30-year Treasury yield reached roughly 5.31 per cent, its highest level since 2007. Japan’s 10-year government bond yield subsequently approached 2.95 per cent, a three-decade high, while German borrowing costs have risen to 15-year highs. The OECD describes the present combination of elevated financing requirements and elevated yields as exceptional compared with the previous two decades. Behind those numbers is a larger structural contest. Governments need capital for debt refinancing, defence, infrastructure, pensions, healthcare and climate resilience. Technology companies require extraordinary sums for artificial-intelligence infrastructure. Energy systems require grids, generation and storage. Businesses require investment. Families require mortgages and credit. These demands do not occupy separate universes. They ultimately encounter the same fundamental economic resource: capital. And when many powerful institutions want more of it simultaneously, the price of money stops being an obscure financial-market variable. It becomes a question of who gets financed, at what price, and at whose expense.

Cancer Vaccines Are Becoming Personal

For more than a century, the word vaccine has largely meant prevention: teach the immune system to recognise a threat before disease takes hold. Cancer is forcing medicine to reconsider that architecture. A new generation of experimental therapies is attempting something considerably more individual: sequence a patient’s tumour, identify mutations particular to that cancer, manufacture instructions corresponding to selected tumour-specific targets, and teach the patient’s immune system to recognise what belongs to the cancer growing inside that particular body. On 19 August, Moderna and Merck announced that their Phase III trial of the investigational personalised mRNA therapy intismeran autogene, used with Merck’s checkpoint inhibitor Keytruda after surgery for high-risk melanoma, achieved statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with Keytruda alone. The global trial enrolled 1,137 patients with resected stage IIB–IV melanoma. No new safety concerns were identified in the announcement. Full detailed Phase III results remain pending. The result matters because this is not simply another medicine administered to everyone carrying the same diagnosis. Intismeran is designed individually. Tumour and normal tissue are sequenced; mutations are analysed computationally; selected neoantigens — abnormal molecular features produced by the tumour — become the targets encoded into an mRNA therapy manufactured for that patient. Earlier Phase IIb evidence provides important context rather than a substitute for the unreleased Phase III detail. At five-year median follow-up, Moderna and Merck reported that intismeran plus Keytruda reduced the risk of recurrence or death by 49 per cent and distant metastasis or death by 59 per cent compared with Keytruda alone in that smaller study. The larger significance therefore extends beyond melanoma. Medicine has spent generations classifying disease so that patients with sufficiently similar conditions can receive sufficiently similar treatments. Personalised cancer vaccines suggest a different possibility: the diagnosis may identify the disease, while the tumour itself helps design the medicine. If that model succeeds across cancers, one of medicine’s great industrial achievements — standardisation — will begin coexisting with its apparent opposite: manufacturing treatment for one.